DuPont to invest in microbiome venture

18:18 PM | June 6, 2019 | Akshita Bhatia

DuPont has announced a strategic investment and partnership with BioMe Oxford (Oxford, UK), which is developing a smart, orally delivered capsule that can sample gut microbiota in both humans and animals. BioMe Oxford is researching and developing ways to sample gut microbiota to understand how diets, ingredients, and probiotics influence gut microbiota. 

DuPont will partner with BioMe Oxford and the University of Sheffield’s Advanced Manufacturing Research Centre (AMRC) to enhance the capsule by researching the impact live microbes have on the gut microbiota. The partnership “will allow us to deepen our understanding of the impact our probiotics and other ingredients have on the microbiome in parts of the GI tract that are very difficult to access today other than through endoscopy procedures,” says Sebastien Guery, leader of DuPont’s microbiome venture business.